RECORD // Company

Curanex Pharmaceuticals Inc

Built 2026-11-22T01:37:59Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (1)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • CURANEX PHARMACEUTICALS INC · Ny corps · same registered legal name as 'Curanex Pharmaceuticals Inc' Possible match based on name, not a shared identifier. Compare the records. Compare

2 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001493152-26-051628

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-2,815,5973 months ended 2026-09-3010-Q2026-11-130001493152-26-0516282026-11-22 01:37 UTCReport an error
Cash and cash equivalents$1,579,689at 2026-09-3010-Q2026-11-130001493152-26-0516282026-11-22 01:37 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue, Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0002025942
Ticker
CURX
EIN
830741390
Record ID
sx:sec:0002025942

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

13 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-13SEC EDGAR company profile2026-11-22 01:37 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-13SEC EDGAR company profile2026-11-22 01:37 UTCReport an error
State of incorporationNV2026-11-13SEC EDGAR company profile2026-11-22 01:37 UTCReport an error
Fiscal year end (MMDD)12312026-11-13SEC EDGAR company profile2026-11-22 01:37 UTCReport an error
Business address2 JERICHO PLAZA,, SUITE101B, JERICHO, NY, 117532026-11-13SEC EDGAR company profile2026-11-22 01:37 UTCReport an error
ExchangesNasdaq2026-11-13SEC EDGAR company profile2026-11-22 01:37 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-4,225,1062025-12-3110-K, XBRL NetIncomeLoss2026-11-22 01:37 UTCReport an error
Total assets (at 2025-12-31)$11,580,1242025-12-3110-K, XBRL Assets2026-11-22 01:37 UTCReport an error
Stockholders' equity (at 2025-12-31)$11,219,0842025-12-3110-K, XBRL StockholdersEquity2026-11-22 01:37 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$5,000,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 01:37 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-10,484,4522025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 01:37 UTCReport an error
Operating lease liabilities (at 2025-12-31)$346,6992025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 01:37 UTCReport an error
8-K Item 3.03, Material (filed 2026-08-17)Modification to Rights of Security Holders. The information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated by reference herein. Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. As previously disclosed by Curanex Pharmaceuticals Inc (the “Company”), on May 31, 2026, the board of directors of the Company (the “Board”) approved by unanimous written consent, and on June 11, 2026, holders of a majority of the outstanding voting power of the Company, acting by written consent, in accordance with the applicable provisions of the Nevada Revised Statutes (“NRS”) and the Company’s Amended and Restated Articles of Incorporation, as amended…2026-08-17SEC EDGAR 8-K 0001493152-26-038764 (text as filed, excerpt)2026-11-22 01:37 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.